U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07525544) titled 'A Study to Investigate the Safety and PK of VH4770359 in Healthy Participants' on April 06.
Brief Summary: VH4770359 (also known as GSK4770359) is an antiretroviral compound. This first-in-human study aims to evaluate the safety, tolerability, and pharmacokinetics (PK) of orally administered VH4770359 in healthy participants. The findings from this study will support the design of future clinical studies of VH4770359 in people living with HIV.
Study Start Date: April 07
Study Type: INTERVENTIONAL
Condition:
HIV Infections
Intervention:
DRUG: VH4770359
Participants will receive the assigned dose formulation of VH4770359 orall...